Kawasaki disease shock syndrome in the COVID-19 pandemic
- PMID: 34278987
- PMCID: PMC8365096
- DOI: 10.1017/S1047951121003280
Kawasaki disease shock syndrome in the COVID-19 pandemic
Abstract
Multisystem inflammatory syndrome in children is a new entity in association with SARS-CoV2. Clinical features of Kawasaki disease were noted from the first reported cases of MIS-C. Before the COVID-19 pandemic, Kawasaki disease shock syndrome was considered to be a distinct and unique form of KD. We present a representative case that prove the current difficulty in clearly distinguishing MIS-C from pre-COVID-19-KDSS and emphasie the overlap of the diagnostic criteria.
Keywords: COVID-19; Kawasaki disease; Kawasaki disease shock syndrome; SARS-CoV2; multisystem inflammatory syndrome in children.
References
-
- Gamez-Gonzalez LB, Moribe-Quintero I, Cisneros-Castolo M, et al.Kawasaki disease shock syndrome: unique and severe subtype of Kawasaki disease. Pediatr Int 2018; 60: 781–790. - PubMed
-
- Noval Rivas M, Porritt RA, Cheng MH, Bahar I, Arditi M.COVID-19-associated multisystem inflammatory syndrome in children (MIS-C): a novel disease that mimics toxic shock syndrome the superantigen hypothesis. J Allergy Clin Immunol 2021; 147: 57–59. DOI: 10.1016/j.jaci.2020.10.008. - DOI - PMC - PubMed
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
